Interferon-Alpha in the Treatment of Philadelphia-Negative Chronic Myeloproliferative Neoplasms. Status and Perspectives

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|12|3|392-419

ISSN： 1389-4501

Source： Current Drug Targets, Vol.12, Iss.3, 2011-01, pp. : 392-419

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Molecular Pathogenesis of Philadelphia Chromosome Negative Chronic Myeloproliferative Neoplasms

By  

Current Cancer Drug Targets, Vol. 11, Iss. 1, 2011-01 ,pp. : 20-30

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging therapies for the treatment of chronic Philadelphia chromosome-negative myeloproliferative neoplasm-associated myelofibrosis

By Gowin Krisstina   Mesa Ruben  

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 12, 2013-12 ,pp. : 1603-1611

Informa Healthcare

Access to resources Recommend Favorite

Current Treatment Concepts of Philadelphia-Negative MPN

By  

Current Cancer Drug Targets, Vol. 11, Iss. 1, 2011-01 ,pp. : 44-55

Bentham Science Publishers

Access to resources Recommend Favorite

Interferon-Alpha in the Treatment of Multiple Myeloma

By  

Current Drug Targets, Vol. 12, Iss. 3, 2011-03 ,pp. : 437-446

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial [Hot Topic: Interferon Alpha2 in the Treatment of Hematological Malignancies. Status and Perspectives (Guest Editor: Hans Carl Hasselbalch)]

By  

Current Drug Targets, Vol. 12, Iss. 3, 2011-03 ,pp. : 387-391

Bentham Science Publishers

Access to resources Recommend Favorite